Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.

Komajda M, Schöpe J, Wagenpfeil S, Tavazzi L, Böhm M, Ponikowski P, Anker SD, Filippatos GS, Cowie MR; QUALIFY Investigators.

Eur J Heart Fail. 2019 Apr 1. doi: 10.1002/ejhf.1459. [Epub ahead of print]

PMID:
30933403
2.

[Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment].

Mareev VY, Fomin IV, Ageev FT, Begrambekova YL, Vasyuk YA, Garganeeva AA, Gendlin GE, Glezer MG, Gote SV, Dovzhenko TV, Kobalava ZD, Koziolova NA, Koroteev AV, Mareev YV, Ovchinnikov AG, Perepech NB, Tarlovskaya EI, CHesnikova AI, Shevchenko AO, Arutyunov GP, Belenkov YN, Galyavich AS, Gilyarevskiy SR, Drapkina OM, Duplyakov DV, Lopatin YM, Sitnikova MY, Skibitskiy VV, SHlyakhto EV.

Kardiologiia. 2018 SJun;58 Suppl 6:1-164. Russian. No abstract available.

PMID:
30081796
3.

A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris.

Shkolnik E, Burneikaite G, Jakutis G, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Vasyuk Y, Laucevicius A, Celutkiene J.

Coron Artery Dis. 2018 Nov;29(7):579-586. doi: 10.1097/MCA.0000000000000648.

PMID:
29912782
4.

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study).

Glezer M, Vasyuk Y, Karpov Y.

Adv Ther. 2018 Mar;35(3):341-352. doi: 10.1007/s12325-018-0681-5. Epub 2018 Mar 5.

5.

[Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].

Makeeva LM, Emelina EI, Gendlin GE, Nikitin IG, Vasyuk YA, Nesvetov VV.

Kardiologiia. 2017 Apr;57(S4):53-60. Russian.

PMID:
29466183
6.

[Possibilities of modern echocardiographic technologies in the early diagnosis of the cardiotoxic effect of chemotherapy drugs anthracycline series in cancer patients].

Vasyuk YA, Nesvetov VV, SHkolnik EL, Fursov SA, Shkolnik LD, Gendlin GE, Emelina EI.

Kardiologiia. 2017 Apr;57(S4):31-37. Review. Russian.

PMID:
29466180
7.

Efficacy of cardiac shock wave therapy in patients with stable angina: The design of randomized, triple blind, sham-procedure controlled study.

Shkolnik E, Burneikaite G, Celutkiene J, Scherbak M, Zuoziene G, Petrauskiene B, Trush E, Laucevicius A, Vasyuk Y.

Anatol J Cardiol. 2018 Feb;19(2):100-109. doi: 10.14744/AnatolJCardiol.2017.8023.

8.

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.

Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators.

Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.

9.

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.

Connolly SJ, Eikelboom JW, Bosch J, Dagenais G, Dyal L, Lanas F, Metsarinne K, O'Donnell M, Dans AL, Ha JW, Parkhomenko AN, Avezum AA, Lonn E, Lisheng L, Torp-Pedersen C, Widimsky P, Maggioni AP, Felix C, Keltai K, Hori M, Yusoff K, Guzik TJ, Bhatt DL, Branch KRH, Cook Bruns N, Berkowitz SD, Anand SS, Varigos JD, Fox KAA, Yusuf S; COMPASS investigators.

Lancet. 2018 Jan 20;391(10117):205-218. doi: 10.1016/S0140-6736(17)32458-3. Epub 2017 Nov 10. Erratum in: Lancet. 2017 Dec 21;:.

PMID:
29132879
10.

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators.

N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27.

11.

[Azilsartan Medoxomil Capabilities in Arterial Hypertension and Obesity].

Vasyuk YA, Shupenina EY, Nesvetov VV, Nesterova EA, Golubkova EI.

Kardiologiia. 2016 Dec;56(11):108-112. Review. Russian.

PMID:
28290827
12.

[Cardiooncology: Current Aspects of Prevention of Anthracycline Toxicity].

Vasyuk YA, Shkolnik EL, Nesterov VV, Shkolnik LD, Varlan GV.

Kardiologiia. 2016 Dec;56(12):72-79. Review. Russian.

PMID:
28290807
13.

[Obesity in metabolic syndrome, as well as kidney dysfunction].

Sadulaeva IA, Vasyuk YA, Trofimenko OS, Yushchuk EN, Ivanova SV, Shupenina EY, Nesterova EA.

Ter Arkh. 2016;88(10):93-98. doi: 10.17116/terarkh201688693-98. Russian.

PMID:
28635857
14.

[Left Atrial Remodeling and Thromboembolic Risk in Patients With Recurrent Atrial Fibrillation].

Shavarov AA, Yusupov AA, Kiyakbaev GK, Vasyuk YA, Moiseev VS.

Kardiologiia. 2015;55(11):37-44. Russian.

PMID:
27125103
15.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

16.

Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study.

Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Vinereanu D, Ambrosio G, Zava D; SMILE-4 Working Party.

J Hypertens. 2013 Jun;31(6):1256-64. doi: 10.1097/HJH.0b013e3283605cd8.

PMID:
23552127
18.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

19.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

20.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

Supplemental Content

Loading ...
Support Center